All publications | Gattefossé

Development of self emulsifying lipid formulations of BCS class II drugs with low to medium lipophilicity

Scientific publication

International Journal of Pharmaceutics, Volume 495, Issue 1, Pages 385-392 - Nov 2015

Vincent Jannin, Stéphanie Chevrier, Matthieu Michenaud, Camille Dumont, Silvia Belotti, Yann Chavant, Fédéric Demarne.

This article describes the work undertaken in Gattefossé R&D labs (St Priest) to develop lipid formulations for low to medium lipophilicity API: piroxicam, nifedipine and curcumin and evaluate the effect of in-vitro digestion on the solubilizing capacity of the formulations.